Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease
Open Access
- 19 February 2011
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 28 (2) , 431-438
Abstract
Advanced glycation end products (AGEs) have a pivotal role in atherosclerosis. We evaluated skin autofluorescence (SAF), a non-invasive measurement of tissue AGE accumulation, in patients with carotid artery stenosis with and without coexisting peripheral artery occlusive disease (PAOD). SAF was measured using the AGE Reader™ in 56 patients with carotid artery stenosis and in 56 age- and sex-matched healthy controls without diabetes, renal dysfunction or known atherosclerotic disease. SAF was higher in patients with carotid artery stenosis compared to the control group: mean 2.81 versus 2.46 (P = 0.002), but especially in the younger age group of 50–60 years old: mean 2.82 versus 1.94 (P = 0.000). Patients with carotid artery stenosis and PAOD proved to have an even higher SAF than patients with carotid artery stenosis only: mean 3.28 versus 2.66 (P = 0.003). Backward linear regression analysis showed that age, smoking, diabetes mellitus, renal function and the presence of PAOD were the determinants of SAF, but carotid artery stenosis was not. SAF is increased in patients with carotid artery stenosis and PAOD. The univariate and multivariate associations of SAF with age, smoking, diabetes, renal insufficiency and PAOD suggest that increased SAF can be seen as an indicator of widespread atherosclerosis.Keywords
This publication has 22 references indexed in Scilit:
- Skin Autofluorescence and Glycemic VariabilityDiabetes Technology & Therapeutics, 2010
- Skin Autofluorescence, a Novel Marker for Glycemic and Oxidative Stress-Derived Advanced Glycation Endproducts: An Overview of Current Clinical Studies, Evidence, and LimitationsDiabetes Technology & Therapeutics, 2006
- Advanced Glycation End ProductsCirculation, 2006
- Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Predicts Mortality in Hemodialysis PatientsJournal of the American Society of Nephrology, 2005
- Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 DiabetesDiabetes, 2005
- Accumulation of Advanced Glycation End Products, Measured as Skin Autofluorescence, in Renal DiseaseAnnals of the New York Academy of Sciences, 2005
- Simple Noninvasive Measurement of Skin AutofluorescenceAnnals of the New York Academy of Sciences, 2005
- Simple non-invasive assessment of advanced glycation endproduct accumulationDiabetologia, 2004
- Glycoxidation and lipoxidation in atherogenesisFree Radical Biology and Medicine, 2000
- Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.Diabetes, 1999